Aurora, Colorado, August 3, 2026
A University of Colorado Anschutz Medical Campus-led multicenter clinical trial has demonstrated that an artificial intelligence (AI)-powered automated oxygen delivery system significantly improves oxygen management in hospitalized patients while reducing clinician workload compared with conventional oxygen therapy. Published in JAMA Internal Medicine and presented at the Military Health System Research Symposium, the SAVE-O2 AI trial evaluated 300 adult patients across four U.S. hospitals receiving supplemental oxygen for conditions including acute respiratory illness, traumatic injury, burns and post-surgical recovery. Patients managed with the O2matic PRO100 automated oxygen titration system remained within their prescribed oxygen target range 85% of the time, compared with 63% for patients receiving standard clinician-managed oxygen therapy. The findings highlight the growing role of AI-enabled medical technologies in improving precision medicine, enhancing patient safety and supporting healthcare professionals through intelligent clinical automation.
AI-Driven Oxygen Delivery Improves Clinical Outcomes
The SAVE-O2 AI trial investigated whether continuous automated oxygen titration could outperform traditional oxygen management, which relies on periodic manual adjustments by nurses and respiratory therapists. The O2matic PRO100 system continuously monitors blood oxygen saturation using a pulse oximeter and automatically adjusts oxygen flow in real time, helping maintain patients within individualized target oxygen ranges throughout the day and night. Researchers reported that patients using the AI-powered system experienced significantly less hypoxemia (low oxygen levels) and reduced hyperoxemia (excess oxygen exposure) while maintaining substantially improved oxygen stability. Importantly, the study found no increase in serious adverse events, demonstrating that automated oxygen management can safely deliver more precise therapy than conventional approaches. Investigators emphasized that maintaining appropriate oxygen levels remains one of the most important yet challenging aspects of inpatient care, as both insufficient and excessive oxygen administration may negatively affect patient outcomes.
Automation Reduces Workload for Healthcare Professionals
Beyond improving oxygen precision, the automated system significantly reduced the number of manual oxygen adjustments required by clinical staff. In traditional hospital settings, oxygen therapy requires repeated bedside assessments and frequent adjustments throughout a patient’s stay, creating additional workload for nurses and respiratory therapists. By automatically responding to continuous oxygen saturation measurements, the AI-powered technology minimizes the need for routine intervention while allowing healthcare professionals to dedicate more time to other critical aspects of patient care. Researchers noted that the technology could become particularly valuable in busy hospital units where clinicians manage multiple high-acuity patients simultaneously. Future studies will further evaluate its impact on workflow efficiency, staffing requirements and healthcare resource utilization, with investigators suggesting that intelligent automation may become an increasingly important component of modern hospital care.
Advertisement
Technology Shows Promise for Civilian and Military Medicine
The findings also demonstrate broader implications for emergency medicine, military healthcare and prehospital care, where rapid clinical decision-making and limited resources often make continuous oxygen management difficult. The study builds upon ongoing research conducted through the CU Anschutz Combat Medicine Research Center, which has focused on improving oxygen therapy for critically ill and injured patients across both civilian and military environments. Researchers believe autonomous oxygen delivery may be especially beneficial during emergency transport, combat casualty care and disaster response, where clinicians must balance multiple urgent tasks while managing limited oxygen supplies. The investigational O2matic PRO100 device was evaluated in the United States under an FDA Investigational Device Exemption (IDE) and has not yet received FDA clearance for commercial use. Despite its investigational status, the strong clinical performance observed in the SAVE-O2 AI trial supports continued evaluation across broader healthcare settings. As hospitals increasingly adopt AI-driven clinical decision support technologies, automated oxygen delivery represents a promising advancement capable of improving patient safety, enhancing treatment precision and transforming one of medicine’s most frequently administered therapies through intelligent real-time automation.
Source: University of Colorado Anschutz press release
